Androgen Deprivation Therapy and High dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial


  • Prostate Cancer


Arizona: Paula Sedivy (480) 945-6896 and Michigan: Maria Pappas (248) 553-0606


  • Prostate cancer

Patients must have a Gleason score of 7-10 and stage T1c-T2b and a PSA of

or a Gleason score of 6 and stage T2c-T4 or >50% positive biopsies and a PSA < 50 ng/ml